How much revenue did Joint generate this year?
Joint has achieved a revenue of 118.52 M USD this year.
Joint Revenue 2024
Joint Revenue
118.52 M USD
Ticker
JYNT
ISIN
US47973J1025
WKN
A12FCC
In 2024, Joint's sales reached 118.52 M USD, a 0.7% difference from the 117.7 M USD sales recorded in the previous year.
The Joint Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 84.41 | 126,94 |
| 2025e | 104.52 | 102,52 |
| 2024e | 118.52 | 90,41 |
| 2023 | 117.7 | 91,04 |
| 2022 | 101.3 | 90,92 |
| 2021 | 80 | 90,38 |
| 2020 | 58.7 | 88,93 |
| 2019 | 48.5 | 88,45 |
| 2018 | 36.7 | 88,28 |
| 2017 | 24.9 | 87,15 |
| 2016 | 20.5 | 85,85 |
| 2015 | 13.8 | 79,71 |
| 2014 | 7.1 | 67,61 |
| 2013 | 6 | 66,67 |
| 2012 | 2.8 | 60,71 |
Joint Revenue, EBIT, Net Income US47973J1025 · A12FCC
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Joint, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Joint from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Joint’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Joint. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Joint’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Joint’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Joint’s growth potential.
Joint Revenue, EBIT and net profit per share
| Date | Joint Revenue | Joint EBIT | Joint Net Income |
|---|---|---|---|
| 2026e | 84.41 M undefined | 11.98 M undefined | 8.42 M undefined |
| 2025e | 104.52 M undefined | 9.32 M undefined | 5.95 M undefined |
| 2024e | 118.52 M undefined | 1.99 M undefined | -1.93 M undefined |
| 2023 | 117.7 M undefined | 559,520 undefined | -9.75 M undefined |
| 2022 | 101.3 M undefined | 1.2 M undefined | 600,000 undefined |
| 2021 | 80 M undefined | 6.1 M undefined | 7.6 M undefined |
| 2020 | 58.7 M undefined | 5.4 M undefined | 13.2 M undefined |
| 2019 | 48.5 M undefined | 3.5 M undefined | 3.3 M undefined |
| 2018 | 36.7 M undefined | 800,000 undefined | 100,000 undefined |
| 2017 | 24.9 M undefined | -2.9 M undefined | -3.4 M undefined |
| 2016 | 20.5 M undefined | -11.5 M undefined | -15.2 M undefined |
| 2015 | 13.8 M undefined | -9.4 M undefined | -8.8 M undefined |
| 2014 | 7.1 M undefined | -1.6 M undefined | -3 M undefined |
| 2013 | 6 M undefined | 400,000 undefined | 200,000 undefined |
| 2012 | 2.8 M undefined | -1.3 M undefined | -700,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2012 | 2.8 M USD | -1.3 M USD | -700,000 USD |
| 2013 | 6 M USD | 400,000 USD | 200,000 USD |
| 2014 | 7.1 M USD | -1.6 M USD | -3 M USD |
| 2015 | 13.8 M USD | -9.4 M USD | -8.8 M USD |
| 2016 | 20.5 M USD | -11.5 M USD | -15.2 M USD |
| 2017 | 24.9 M USD | -2.9 M USD | -3.4 M USD |
| 2018 | 36.7 M USD | 800,000 USD | 100,000 USD |
| 2019 | 48.5 M USD | 3.5 M USD | 3.3 M USD |
| 2020 | 58.7 M USD | 5.4 M USD | 13.2 M USD |
| 2021 | 80 M USD | 6.1 M USD | 7.6 M USD |
| 2022 | 101.3 M USD | 1.2 M USD | 600,000 USD |
| 2023 | 117.7 M USD | 559,520 USD | -9.75 M USD |
| 2024e | 118.52 M USD | 1.99 M USD | -1.93 M USD |
| 2025e | 104.52 M USD | 9.32 M USD | 5.95 M USD |
| 2026e | 84.41 M USD | 11.98 M USD | 8.42 M USD |
Joint stock margins US47973J1025 · A12FCC
The Joint margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Joint. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Joint.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Joint's sales revenue. A higher gross margin percentage indicates that the Joint retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Joint's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Joint's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Joint's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Joint. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Joint's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Joint Margin History
| Joint Gross margin | Joint Profit margin | Joint EBIT margin | Joint Profit margin |
|---|---|---|---|
| 2026e | 91.04 % | 14.2 % | 9.97 % |
| 2025e | 91.04 % | 8.91 % | 5.69 % |
| 2024e | 91.04 % | 1.68 % | -1.63 % |
| 2023 | 91.04 % | 0.48 % | -8.29 % |
| 2022 | 90.92 % | 1.18 % | 0.59 % |
| 2021 | 90.38 % | 7.63 % | 9.5 % |
| 2020 | 88.93 % | 9.2 % | 22.49 % |
| 2019 | 88.45 % | 7.22 % | 6.8 % |
| 2018 | 88.28 % | 2.18 % | 0.27 % |
| 2017 | 87.15 % | -11.65 % | -13.65 % |
| 2016 | 85.85 % | -56.1 % | -74.15 % |
| 2015 | 79.71 % | -68.12 % | -63.77 % |
| 2014 | 67.61 % | -22.54 % | -42.25 % |
| 2013 | 66.67 % | 6.67 % | 3.33 % |
| 2012 | 60.71 % | -46.43 % | -25 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2012 | 60.71 % | -46.43 % | -25 % |
| 2013 | 66.67 % | 6.67 % | 3.33 % |
| 2014 | 67.61 % | -22.54 % | -42.25 % |
| 2015 | 79.71 % | -68.12 % | -63.77 % |
| 2016 | 85.85 % | -56.1 % | -74.15 % |
| 2017 | 87.15 % | -11.65 % | -13.65 % |
| 2018 | 88.28 % | 2.18 % | 0.27 % |
| 2019 | 88.45 % | 7.22 % | 6.8 % |
| 2020 | 88.93 % | 9.2 % | 22.49 % |
| 2021 | 90.38 % | 7.63 % | 9.5 % |
| 2022 | 90.92 % | 1.18 % | 0.59 % |
| 2023 | 91.04 % | 0.48 % | -8.29 % |
| 2024e | 91.04 % | 1.68 % | -1.63 % |
| 2025e | 91.04 % | 8.91 % | 5.69 % |
| 2026e | 91.04 % | 14.2 % | 9.97 % |
Joint Aktienanalyse
What does Joint do?
The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Joint's Sales Figures
The sales figures of Joint originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Joint’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Joint's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Joint’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Joint stock
How much was the turnover of the company Joint compared to the previous year?
The revenue of Joint has increased by 0.7% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Joint?
The revenue of Joint is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Joint measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Joint so important for investors?
The revenue of Joint is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Joint pay?
Over the past 12 months, Joint paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Joint is expected to pay a dividend of 0 USD.
What is the dividend yield of Joint?
The current dividend yield of Joint is .
When does Joint pay dividends?
Joint pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Joint?
Joint paid dividends every year for the past 0 years.
What is the dividend of Joint?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Joint located?
Joint is assigned to the 'Health' sector.
Wann musste ich die Aktien von Joint kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Joint from 9/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.
When did Joint pay the last dividend?
The last dividend was paid out on 9/9/2024.
What was the dividend of Joint in the year 2023?
In the year 2023, Joint distributed 0 USD as dividends.
In which currency does Joint pay out the dividend?
The dividends of Joint are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Joint
Our stock analysis for Joint Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Joint Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
